Atrial fibrillation Trials in Arezzo, Italy
Conditions / Atrial fibrillation / Arezzo, Italy
Clinical trials for Atrial fibrillation investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00262600 | Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate | COMPLETED | PHASE3 |
| NCT02866175 | Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | COMPLETED | PHASE3 |
| NCT02164864 | Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI) | COMPLETED | PHASE3 |
| NCT00808067 | RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial | COMPLETED | PHASE3 |
| NCT03909386 | Non-interventional Study on Patients With Atrial Fibrillation and Cancer | COMPLETED | — |
| NCT02100228 | Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) | COMPLETED | PHASE4 |
| NCT05757869 | A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02942576 | Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation | COMPLETED | PHASE3 |
| NCT02944019 | Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation | COMPLETED | — |
| NCT05643573 | A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke | TERMINATED | PHASE3 |